⌘K

Home/Filings/4/0001209191-22-007260

4//SEC Filing

CARLSON MARILYN R. 4

Accession 0001209191-22-007260

CIK 0001403708other

View on SEC.gov Company Profile

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 5:21 PM ET

Size

5.5 KB

Accession

0001209191-22-007260

Insider Transaction Report

Form 4

Period: 2022-02-02

Evoke Pharma IncEVOK

CARLSON MARILYN R.

Chief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2022-02-02+100,000→ 100,000 total
Exercise: $0.55Exp: 2032-02-01→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]The option shall vest at the rate of 1/48th of the original number of shares on each monthly anniversary of January 1, 2022, subject to the reporting person's continuous service to the issuer on each such vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Evoke Pharma Inc

CIK 0001403708

Entity typeother

Related Parties

1

filerCIK 0001592848

Filing Metadata

Form type: 4
Filed: Feb 3, 7:00 PM ET
Accepted: Feb 4, 5:21 PM ET
Size: 5.5 KB

View on SEC.gov